Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Src is the primary target of aripiprazole, an atypical antipsychotic drug, in its anti-tumor action.

Kim MS, Yoo BC, Yang WS, Han SY, Jeong D, Song JM, Kim KH, Aravinthan A, Kim JH, Kim JH, Kim SC, Cho JY.

Oncotarget. 2017 Dec 8;9(5):5979-5992. doi: 10.18632/oncotarget.23192. eCollection 2018 Jan 19.

2.

An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Brown RW, Kirby SL, Denton AR, Dose JM, Cummins ED, Drew Gill W, Burgess KC.

Schizophr Res. 2018 Apr;194:107-114. doi: 10.1016/j.schres.2017.03.024. Epub 2017 Mar 14.

PMID:
28314679
3.

Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases.

Chong ZZ, Changyaleket B, Xu H, Dull RO, Schwartz DE.

Curr Med Chem. 2016;23(15):1571-96. Review.

PMID:
27048377
4.

Genetic Evaluation of Schizophrenia Using the Illumina HumanExome Chip.

Moons T, De Hert M, Gellens E, Gielen L, Sweers K, Jacqmaert S, van Winkel R, Vandekerckhove P, Claes S.

PLoS One. 2016 Mar 30;11(3):e0150464. doi: 10.1371/journal.pone.0150464. eCollection 2016.

5.

Beneficial action of resveratrol: How and why?

Diaz-Gerevini GT, Repossi G, Dain A, Tarres MC, Das UN, Eynard AR.

Nutrition. 2016 Feb;32(2):174-8. doi: 10.1016/j.nut.2015.08.017. Epub 2015 Sep 25. Review.

PMID:
26706021
6.

Impaired autophagy in hilar mossy cells of the dentate gyrus and its implication in schizophrenia.

Yuan Y, Wang H, Wei Z, Li W.

J Genet Genomics. 2015 Jan 20;42(1):1-8. doi: 10.1016/j.jgg.2014.12.001. Epub 2014 Dec 23.

PMID:
25619597
7.

Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses.

Ibáñez K, Boullosa C, Tabarés-Seisdedos R, Baudot A, Valencia A.

PLoS Genet. 2014 Feb 20;10(2):e1004173. doi: 10.1371/journal.pgen.1004173. eCollection 2014 Feb.

8.

The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition.

Chow F, Gong Y, Lippa CF.

Am J Alzheimers Dis Other Demen. 2014 Jun;29(4):303-10. doi: 10.1177/1533317513518645. Epub 2014 Jan 13. Review.

PMID:
24421411
9.

Increased susceptibility to apoptosis in cultured fibroblasts from antipsychotic-naïve first-episode schizophrenia patients.

Gassó P, Mas S, Molina O, Lafuente A, Bernardo M, Parellada E.

J Psychiatr Res. 2014 Jan;48(1):94-101. doi: 10.1016/j.jpsychires.2013.09.017. Epub 2013 Oct 10.

PMID:
24128664
10.

Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].

Katsel P, Tan W, Fam P, Purohit DP, Haroutunian V.

PLoS One. 2013 Jul 5;8(7):e68361. doi: 10.1371/journal.pone.0068361. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/59ecb64c-1f53-4d8a-903c-2f835e78bd13.

11.

Association between polymorphisms in the genes for tumor suppressor protein p53 and its regulator NAD(P)H: quinone oxidoreductase 1 (NQO1) and schizophrenia in a Syrian study cohort.

Lajin B, Alachkar A, Michati R, Alhaj Sakur A.

Arch Med Res. 2013 Feb;44(2):121-6. doi: 10.1016/j.arcmed.2012.12.009. Epub 2013 Jan 27.

PMID:
23360829
12.

The differences between typical and atypical antipsychotics: the effects on neurogenesis.

Nandra KS, Agius M.

Psychiatr Danub. 2012 Sep;24 Suppl 1:S95-9. Review.

13.

Glyoxalase I retards renal senescence.

Ikeda Y, Inagi R, Miyata T, Nagai R, Arai M, Miyashita M, Itokawa M, Fujita T, Nangaku M.

Am J Pathol. 2011 Dec;179(6):2810-21. doi: 10.1016/j.ajpath.2011.08.023. Epub 2011 Oct 12.

14.

Dysbindin-1, a schizophrenia-related protein, facilitates neurite outgrowth by promoting the transcriptional activity of p53.

Ma X, Fei E, Fu C, Ren H, Wang G.

Mol Psychiatry. 2011 Nov;16(11):1105-16. doi: 10.1038/mp.2011.43. Epub 2011 Apr 19.

PMID:
21502952
15.

Convergent evidence of the contribution of TP53 genetic variation (Pro72Arg) to metabolic activity and white matter volume in the frontal lobe in schizophrenia patients.

Molina V, Papiol S, Sanz J, Rosa A, Arias B, Fatjó-Vilas M, Calama J, Hernández AI, Bécker J, Fañanás L.

Neuroimage. 2011 May 1;56(1):45-51. doi: 10.1016/j.neuroimage.2011.01.076. Epub 2011 Feb 4.

PMID:
21296169
16.

Investigation of Differences in P53 Gene Polymorphisms between Schizophrenia and Lung Cancer Patients in the Turkish Population.

Ozbey U, Yüce H, Namli M, Elkiran T.

Genet Res Int. 2011;2011:483851. doi: 10.4061/2011/483851. Epub 2011 Mar 3.

17.

Association of DRD4 uVNTR and TP53 codon 72 polymorphisms with schizophrenia: a case-control study.

Lung FW, Shu BC, Kao WT, Chen CN, Ku YC, Tzeng DS.

BMC Med Genet. 2009 Dec 29;10:147. doi: 10.1186/1471-2350-10-147.

18.

Evidence for association between structural variants in lissencephaly-related genes and executive deficits in schizophrenia or bipolar patients from a Spanish isolate population.

Tabarés-Seisdedos R, Mata I, Escámez T, Vieta E, López-Ilundain JM, Salazar J, Selva G, Balanzá V, Rubio C, Martínez-Arán A, Valdés-Sánchez L, Geijo-Barrientos E, Martínez S.

Psychiatr Genet. 2008 Dec;18(6):313-7. doi: 10.1097/YPG.0b013e3283118725.

PMID:
19018238
19.

A tail of two signals: the C terminus of the A(2A)-adenosine receptor recruits alternative signaling pathways.

Gsandtner I, Freissmuth M.

Mol Pharmacol. 2006 Aug;70(2):447-9. Epub 2006 May 17.

20.

Apoptosis and schizophrenia: a pilot study based on dermal fibroblast cell lines.

Catts VS, Catts SV, McGrath JJ, Féron F, McLean D, Coulson EJ, Lutze-Mann LH.

Schizophr Res. 2006 May;84(1):20-8. Epub 2006 Apr 19.

PMID:
16626937

Supplemental Content

Loading ...
Support Center